MedTech Acquisition Corporation

MTAC · NASDAQ
Analyze with AI
$11.34+$1.78 (+18.67%)
At close:Aug 10, 2023, 8:00 PM UTC
P/E TTM-4.56
P/B TTM-11.95
P/S TTM6.1
Dividend Yield0%
EPS$0.05
Beta-0.02074
Valuation
PEG Ratio0.06
FCF Yield-9.04%
EV / EBITDA-7.65
More On Valuation »
Quality
ROIC-121.69%
Gross Margin84.04%
Cash Conv. Ratio1.95
More On Quality »
Growth
Revenue 3Y CAGR–
FCF Growth0.00%
More On Growth »
Safety
Net Debt / EBITDA-0.34
Interest Coverage-13.95
More On Safety »
Efficiency
Inventory Turnover1.96
Cash Conv. Cycle231.67
More On Efficiency »

MedTech Acquisition Corporation (MTAC) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is MedTech Acquisition Corporation (MTAC) stock price today?

As of Aug 10, 2023, 8:00 PM UTC, MedTech Acquisition Corporation (MTAC) stock is trading at $11.34. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date MTAC stock quotes for informed trading decisions.

What is MedTech Acquisition Corporation's market capitalization?

MedTech Acquisition Corporation (MTAC) has a market capitalization of approximately $83.9M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare MedTech Acquisition Corporation's size relative to other companies in the USD market. The market cap figure updates automatically as the MTAC stock price changes.

What is the 52-week range for MedTech Acquisition Corporation stock?

MedTech Acquisition Corporation (MTAC) stock has traded in a 52-week range of $8.43 — $12.83. The 52-week range shows the highest and lowest prices at which MTAC traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current MedTech Acquisition Corporation stock price to this range provides context for recent price action.

How much trading volume does MedTech Acquisition Corporation stock have?

MedTech Acquisition Corporation (MTAC) stock recently traded approximately 176.3K shares. Trading volume indicates market liquidity and investor interest in MTAC. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting MedTech Acquisition Corporation stock.

Does MedTech Acquisition Corporation pay dividends to shareholders?

Yes, MedTech Acquisition Corporation (MTAC) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate MedTech Acquisition Corporation stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is MedTech Acquisition Corporation's intraday price range?

Today, MedTech Acquisition Corporation (MTAC) stock has traded in a range of $8.96 — $12.83. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring MTAC's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get MedTech Acquisition Corporation stock data?

AlphaPilot sources real-time MTAC stock quotes, fundamental financial data, and historical price charts for MedTech Acquisition Corporation from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The MedTech Acquisition Corporation stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of MTAC stock performance.